#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuroendocrine tumour of the lung Bile acid synthesis disorder Amyotrophic lateral sclerosis gene carrier Anti-neutrophil cytoplasmic antibody positive vasculitis Pulmonary sarcoidosis Follicle centre lymphoma follicular grade I, II – III Congenital leptin deficiency Acute myeloid leukaemia Autoimmune disorder Endometrial cancer Mantle cell lymphoma refractory Nephropathy Acute hepatic failure Thalassaemia Adenocarcinoma gastric More trials…

    Learn about Rare Diseases

    Familial haemophagocytic lymphohistiocytosis – Life with Disease Cholangitis sclerosing – Life with Disease Thrombotic thrombocytopenic purpura Mantle cell lymphoma refractory – Treatment Haemophilia B with anti factor IX – Diagnostics Medulloblastoma – Trials in Disease Activated PI3 kinase delta syndrome – Treatment Small intestine leiomyosarcoma – Treatment Shprintzen-Goldberg syndrome – Basic Information Uterine leiomyosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    [18F]DED SECRETIN SYNTHETIC HUMAN Lithium Sulphate, Anhydrous Cedazuridine Lacosamide Ecoo16 Ontasameran Dextrose Bp Solrikitug Etidronate Disodium Ptg-Carcik-Cd19 Timrepigene Emparvovec ARLOCABTAGENE AUTOLEUCEL Quetiapine Magnesium Sulfate Heptahydrate SGT-003 Allo-647 Ripasudil Benzocaine Elinzanetant More therapies…

    Learn about Your Condition

    Vasospasm Angiosarcoma recurrent Oropharyngeal cancer Obstructive pancreatitis Primary myelofibrosis Von Willebrand's disease Cardiac sarcoidosis Diffuse large B-cell lymphoma Hydrocephalus Vertigo Metabolic surgery Neuroblastoma Arthralgia Intellectual disability Oesophageal food impaction More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Critical illness

  • Study on Fish Oil Emulsion for Preventing Atrial Fibrillation in High-Risk Cardiac Surgery Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Critical illness
    Investigated Drugs:
    • Glycerol
    • Highly Refined Fish Oil
    • Purified Egg Phospholipids
    Germany

  • Study on the Effectiveness and Safety of Extended vs. Intermittent Infusion of Meropenem in Critically Ill Children with Suspected or Proven Infection

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Critical illness
    Investigated Drugs:
    • Meropenem Anhydrous
    • Meropenem Trihydrate
    • Ceftriaxone
    Hungary

  • Study on Midazolam Hydrochloride: Comparing Subcutaneous and Intravenous Use in Adults with Terminal Illness in Palliative Care

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Critical illness
    Investigated Drugs:
    • Midazolam Hydrochloride
    Norway

  • Study on the Effects of Antibiotic Monitoring in ICU Patients Using Meropenem and Drug Combination

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Critical illness
    Investigated Drugs:
    • Daptomycin
    • Meropenem
    • Piperacillin
    Spain

  • Study on Hydrocortisone and Fludrocortisone for Adults with Critical Illness-Related Corticosteroid Insufficiency

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Critical illness
    Investigated Drugs:
    • Fludrocortisone Acetate
    • Hydrocortisone Hemisuccinate
    • Tetracosactide
    France

  • Study on Vancomycin Hydrochloride for Treating Serious Infections in Critically Ill Adults Using a Precision Dosing Tool

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Critical illness
    Investigated Drugs:
    • Vancomycin Hydrochloride
    Estonia
Previous Page
1 2 3

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!